MercyK.M.GordonK.B.PallerA.S.. Patient satisfaction and quality of life in psoriasis and psoriatic arthritis.JAMA.2014; 312(24): 2676–2677.
2.
TakeshitaJ.Callis DuffinK.ShinD.B.Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.J Am Acad Dermatol.2014; 71(4): 633–641.
3.
LangleyR.G.ElewskiB.E.LebwohlM.Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials.N Engl J Med.2014; 371(4): 326–38.
4.
LebwohlM.StroberB.MenterA.Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.N Engl J Med.2015; 373: 1318–28.
5.
GriffithsC.E.ReichK.LebwohlM.Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.Lancet.2015; 386: 541–51.